Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine

View source ↗

Summary

An observational, real-world study evaluating how well atogepant works in adults with migraine, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Qulipta (atogepant)

Snippet

Sponsor: AbbVie | Conditions: Migraine | Status: RECRUITING